Home » Topics » BioWorld Science

BioWorld Science
RSS

Topline data presented from global phase II trial of SEP-4199 in bipolar I depression

July 8, 2020

Good vs. evil in the synovial joint

July 8, 2020

Noncoding mutations contribute to heart disease

July 8, 2020

Immune Regulation and DynPort partner to advance IRL-201104 for COVID-19-related ARDS

July 7, 2020

European Commission approves Enerzair Breezhaler for uncontrolled asthma

July 7, 2020

Cabaletta opens enrollment in phase I study of DSG3-CAART in mucosal-dominant pemphigus vulgaris

July 7, 2020

Otonomy reports treatment response in phase I/II trial of OTO-313 for tinnitus

July 7, 2020

ADGRG1 promotes TNBC progression and is a therapeutic druggable target

July 7, 2020

Dimerix advances understanding of DMX-700 in COPD

July 7, 2020

FDA places clinical hold on MELANI-01 study

July 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...